Entegris Stock - Analyst consensus points to steady earnings path

Edited by ad hoc news Analyst & Consensus Desk. Verified prior to publication on 06/17/2026, 14:15 CET. Details in the imprint.

Entegris (US29265X1054) sits in a semiconductor industry still digesting last year's volatility. With no new company announcement on Wednesday, the focus shifts to what current analyst estimates imply for the stock.

What the estimates signal

According to recent consensus data compiled by financial portals, analysts expect Entegris to deliver mid-single-digit revenue growth in the current fiscal year, with earnings per share recovering from last year's downturn as wafer fab utilization gradually improves.

Several houses keep a constructive stance on the stock, with a majority of ratings clustered in the Buy and Overweight camp, while a smaller group recommends Hold. Overall, the consensus points to modest upside against the current price rather than a dramatic re-rating.

Valuation and rating landscape

On common valuation metrics such as forward price-earnings and enterprise value to EBITDA, Entegris trades at a premium to some diversified semiconductor equipment peers, reflecting its more specialized role in critical materials and process solutions.

Against this backdrop, analysts' average 12-month price targets indicate that much of the recovery story is already priced in, even though several bullish voices still highlight Entegris' exposure to advanced nodes, high bandwidth memory and broader AI-related capacity investments over the coming years.

The business behind the stock

Entegris generates most of its revenue by supplying advanced materials, filtration and contamination-control solutions used in semiconductor manufacturing, including critical process chemistries, specialty gases, and yield-enhancing filters that help chipmakers run cleaner, more efficient fabs at ever-smaller geometries.

Where the stock trades today

Entegris shares trade on Nasdaq in US dollars; the latest verified quote and market statistics are available on major exchange and financial-data portals.

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.